235 related articles for article (PubMed ID: 29774578)
1. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis.
Lian M; Wang Q; Jiang X; Zhang J; Wei Y; Li Y; Li B; Chen W; Zhang H; Miao Q; Peng Y; Xiao X; Sheng L; Zhang W; Fang J; Tang R; Gershwin ME; Ma X
Hepatology; 2018 Nov; 68(5):1922-1936. PubMed ID: 29774578
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G4-related hepatobiliary disease.
Lee HE; Zhang L
Semin Diagn Pathol; 2019 Nov; 36(6):423-433. PubMed ID: 31358425
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G4-related sclerosing cholangitis.
Tanaka A
J Dig Dis; 2019 Jul; 20(7):357-362. PubMed ID: 31112324
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in IgG4-related disease, autoimmune pancreatitis and sclerosing cholangitis.
Okazaki K; Uchida K
Nihon Rinsho; 2017 Mar; 75(3):450-454. PubMed ID: 30566790
[TBL] [Abstract][Full Text] [Related]
5. Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Cargill T; Makuch M; Sadler R; Lighaam LC; Peters R; van Ham M; Klenerman P; Bateman A; Rispens T; Barnes E; Culver EL
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00020. PubMed ID: 31033594
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related sclerosing cholangitis- A great mimicker.
Nayak HK; Bhat SJ; Panigrahi MK; Chouhan I; Kumar C; Samal SC
Indian J Gastroenterol; 2020 Dec; 39(6):614-618. PubMed ID: 33156480
[TBL] [Abstract][Full Text] [Related]
7. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
8. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
[TBL] [Abstract][Full Text] [Related]
9. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.
Lleo A; Bian Z; Zhang H; Miao Q; Yang F; Peng Y; Chen X; Tang R; Wang Q; Qiu D; Fang J; Sobacchi C; Villa A; Di Tommaso L; Roncalli M; Gershwin ME; Ma X; Invernizzi P
PLoS One; 2016; 11(9):e0159612. PubMed ID: 27631617
[TBL] [Abstract][Full Text] [Related]
11. [Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].
Li BL; Xiao JC
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):508-512. PubMed ID: 31269612
[TBL] [Abstract][Full Text] [Related]
12. Two cases of immunoglobulin G4-related sclerosing cholangitis in which transabdominal ultrasonography was useful in diagnosis and follow-up observation.
Kobori I; Suda T; Nakamoto A; Saito H; Okawa O; Sudo R; Gyotoku Y; Katayama Y; Tamano M
J Med Ultrason (2001); 2016 Apr; 43(2):271-7. PubMed ID: 27033871
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis.
Zen Y; Quaglia A; Portmann B
Histopathology; 2011 Feb; 58(3):414-22. PubMed ID: 21348891
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics.
Zen Y; Nakanuma Y; Portmann B
Semin Diagn Pathol; 2012 Nov; 29(4):205-11. PubMed ID: 23068299
[TBL] [Abstract][Full Text] [Related]
15. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G4-related sclerosing cholangitis.
Goodchild G; Pereira SP; Webster G
Korean J Intern Med; 2018 Sep; 33(5):841-850. PubMed ID: 30045615
[TBL] [Abstract][Full Text] [Related]
17. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis.
Ohno Y; Kumagi T; Imamura Y; Kuroda T; Koizumi M; Watanabe T; Yoshida O; Tokumoto Y; Takeshita E; Abe M; Harada K; Hiasa Y
Clin J Gastroenterol; 2018 Feb; 11(1):62-68. PubMed ID: 29094322
[TBL] [Abstract][Full Text] [Related]
19. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
[TBL] [Abstract][Full Text] [Related]
20. Isolated intrapancreatic IgG4-related sclerosing cholangitis.
Nakazawa T; Ikeda Y; Kawaguchi Y; Kitagawa H; Takada H; Takeda Y; Makino I; Makino N; Naitoh I; Tanaka A
World J Gastroenterol; 2015 Jan; 21(4):1334-43. PubMed ID: 25632210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
